Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden
- 19 October 2017
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 46 (1) , 15-24
Abstract
Rotavirus is the major cause of gastroenteritis in children throughout the world. Every year, a large number of children aged < 5 years die from rotavirus-related diarrhoeal diseases. Though these infections are vaccine-preventable, the vast majority of children in low-income countries suffer from the infection. The situation leads to severe economic loss and constitutes a major public health problem.Keywords
This publication has 127 references indexed in Scilit:
- Changing profile of rotavirus genotypes in Bangladesh, 2006–2012BMC Infectious Diseases, 2013
- Understanding Reduced Rotavirus Vaccine Efficacy in Low Socio-Economic SettingsPLOS ONE, 2012
- Intradermal delivery of vaccines: potential benefits and current challengesBulletin of the World Health Organization, 2011
- Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccineBMC Biology, 2010
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?The Journal of Infectious Diseases, 2009
- Rotaviruses: From Pathogenesis to VaccinationGastroenterology, 2009
- Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?Vaccine, 2008
- Prevalence of G2P[4] and G12P[6] Rotavirus, BangladeshEmerging Infectious Diseases, 2007
- The paediatric burden of rotavirus disease in EuropeEpidemiology and Infection, 2006